Indeed, methylation of genes such as MGMT, RAR-b, RASSF1A, p16INK4a, and DAPK have been reported in the serum DNA of lung cancer patients and can be considered as a tumor marker [73,74,75,76,77]. Here, CDKN2A is linked to lung cancer.